Addenbrooke's Cognitive Examination III (ACE-III) and mini-ACE for the detection of dementia and mild cognitive impairment
journal contribution
posted on 2019-06-10, 13:47 authored by LC Beishon, AP Batterham, TJ Quinn, CP Nelson, RB Panerai, T Robinson, VJ HauntonThis is a protocol for a Cochrane Review (Diagnostic test accuracy). The objectives are as follows: To assess the diagnostic test accuracy of the Addenbrooke's Cognitive Examination-III (ACE-III) and the mini-ACE, for the screening of all-cause dementia, dementia subtypes (Alzheimer's disease, vascular dementia, frontotemporal dementia, Lewy body dementia), and mild cognitive impairment, across all healthcare settings at all prespecified thresholds.
Funding
LCB is a Research Fellow supported by the Dunhill Medical Trust. TGR is a Senior Investigator for the National Institute for Health Research.
History
Citation
Cochrane Database of Systematic Reviews, 2019, 3:CD013282.Author affiliation
/Organisation/COLLEGE OF LIFE SCIENCES/School of Medicine/Department of Cardiovascular SciencesVersion
- VoR (Version of Record)
Published in
Cochrane Database of Systematic ReviewsPublisher
Cochrane Collaboration, Wileyeissn
1469-493XCopyright date
2019Publisher DOI
Publisher version
https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013282/fullNotes
The file associated with this record is under embargo until 12 months after publication, in accordance with the publisher's self-archiving policy. The full text may be available through the publisher links provided above.Language
enAdministrator link
Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC